Aiatella, a Helsinki, Finland-based medtech startup, raised €2M in funding.
The round was led by Nordic Science Investments, with participation from Specialist VC, Harjavalta Ventures, Business Finland, and a syndicate of angel investors.
The company intends to use the funds to expand operations and its R&D efforts.
Led by CEO Jack Parker, Aiatella provides multi-modal Automated Image Measurement (AIM) technology that uses images from prevalent technologies like MRI, CT, and ultrasound to analyse vascular imaging, detecting, and quantifying abnormalities and changes over time in at-risk patients. Automated analysis makes these tasks take minutes, allowing clinicians to focus more on patient care.
The company is currently in medical approval processes in several countries across Europe and North America, including the UK, France, and the United States.
FinSMEs
04/06/2025